aptiganel and Brain Ischemia
aptiganel has been researched along with Brain Ischemia in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Aronowski, J; Grotta, JC; Palusinski, R; Piriyawat, P; Strong, R; Zhao, X | 1 |
Barber, PA; Buchan, AM; Hill, MD; Hoyte, L | 1 |
Aronowski, J; Grotta, JC; Ostrow, P; Samways, E; Strong, R; Zivin, JA | 1 |
Lees, KR | 1 |
Kawasaki-Yatsugi, S; Shimizu-Sasamata, M; Yamaguchi, T; Yatsugi, S | 1 |
Albers, GW; Goldstein, LB; Hall, D; Lesko, LM | 1 |
Albers, GW; Goldstein, LB | 1 |
Reviews
2 review(s) available for aptiganel and Brain Ischemia
Article | Year |
---|---|
The rise and fall of NMDA antagonists for ischemic stroke.
Topics: Animals; Brain Ischemia; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Antagonists; Guanidines; Humans; Indoles; Ischemia; N-Methylaspartate; Neurons; Pipecolic Acids; Receptors, N-Methyl-D-Aspartate; Stroke | 2004 |
Cerestat and other NMDA antagonists in ischemic stroke.
Topics: Brain Ischemia; Cerebrovascular Disorders; Excitatory Amino Acid Antagonists; Guanidines; Humans; Receptors, N-Methyl-D-Aspartate | 1997 |
Trials
1 trial(s) available for aptiganel and Brain Ischemia
Article | Year |
---|---|
Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Drug Administration Schedule; Excitatory Amino Acid Antagonists; Female; Guanidines; Humans; Male; Middle Aged; Neuroprotective Agents; Stroke; Survival Analysis; Time Factors | 2001 |
Other Studies
4 other study(ies) available for aptiganel and Brain Ischemia
Article | Year |
---|---|
Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.
Topics: Animals; Brain Ischemia; Caffeine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Ethanol; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Guanidines; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Phosphodiesterase Inhibitors; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Time Factors; Treatment Outcome | 2010 |
Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats.
Topics: Acute Disease; Animals; Biological Assay; Brain; Brain Ischemia; Guanidines; Hypothermia, Induced; Male; Neuroprotective Agents; Rats; Rats, Inbred SHR; Receptors, N-Methyl-D-Aspartate; Staining and Labeling; Tetrazolium Salts; Time Factors | 1994 |
Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats.
Topics: Animals; Brain Ischemia; Cerebral Arteries; Dose-Response Relationship, Drug; Guanidines; Injections, Intravenous; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Time Factors | 1998 |
Patient safety in trials of therapy for acute ischemic stroke.
Topics: Brain Ischemia; Clinical Trials as Topic; Guanidines; Humans; Neuroprotective Agents; Safety; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |